ANGELA VALLEJO: Open Payments
NPI 1841514619 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 74 payments from 21 companies in 2025. Trend: 2023 $2,164 · 2024 $1,949 · 2025 $1,357
Food & beverage: $1,272Education: $85
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $223 |
| Sumitomo Pharma America, Inc. | 7 | $174 |
| Astellas Pharma US Inc | 4 | $146 |
| GlaxoSmithKline, LLC. | 7 | $136 |
| Novo Nordisk Inc | 7 | $123 |
| Phathom Pharmaceuticals, Inc. | 5 | $71 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Lilly USA, LLC | 3 | $64 |
| PFIZER INC. | 3 | $55 |
Products named: GEMTESA, TRELEGY ELLIPTA, EVENITY, OTEZLA, VOQUEZNA, GARDASIL 9, CAPLYTA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
